Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Eli Lilly ELORA-TZP study shows that amylin drug combination leads to a 23% weight loss

Eli Lilly ELORA-TZP study shows that amylin drug combination leads to a 23% weight loss

智通财经智通财经2026/09/30 14:36
Show original
Eli Lilly (LLY.US) reports ELORA-TZP study results, with its amylin-insulin drug combination achieving a 23% weight loss effect in the study.
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!